Hello friends! Today, we’re diving deep into a topic that is super interesting for stock market enthusiasts — FIGS Stock Analysis. Whether you’re a long-term investor or just curious about healthcare apparel stocks, this article will give you a clear picture of FIGS’ stock price, financials, growth potential, and market performance, all updated for 2026. I’ll also share my personal insights to help you make informed investment decisions. Let’s get started!
Introduction to FIGS
FIGS, Inc. is a healthcare apparel company that has made waves in the stock market and the medical community alike. Founded in 2013 in Santa Monica, California, FIGS creates stylish and functional scrubs, lab coats, and medical apparel for doctors, nurses, and healthcare professionals.
The company became popular because it focuses on comfort, style, and quality, combined with a direct-to-consumer sales model. Since its IPO in 2021, FIGS has been closely watched by investors due to its innovative approach and growing market presence.
Company Overview
Here’s a quick snapshot of the company:
| Feature | Details |
|---|---|
| Company Name | FIGS, Inc. |
| Founded | 2013 |
| Headquarters | Santa Monica, California |
| Industry | Healthcare Apparel & Lifestyle |
| Ticker Symbol | FIGS |
| Exchange | NYSE |
| Business Model | Direct-to-consumer sales of scrubs, medical apparel, and accessories |
Key Takeaway: FIGS has positioned itself as a premium brand in healthcare apparel, leveraging online sales and direct consumer engagement to boost growth.
FIGS Stock Performance Overview
FIGS stock has seen high volatility since its IPO, influenced by market trends, earnings reports, and investor sentiment.
Current Snapshot (2026)
- Stock Price: ~$10–12 per share
- Market Capitalization: ~$1.9 Billion
- Exchange: NYSE
- Industry: Consumer Cyclical / Apparel Manufacturing
Observation: The stock has stabilized compared to the wild swings in 2022–2024 but still shows occasional volatility due to market conditions.
Historical Stock Price Trends
Understanding past performance helps us predict future trends. Here’s a quick overview:
| Year | Price Range (Approx.) |
|---|---|
| 2021 (IPO) | $16–19 |
| 2022 | $14–18 |
| 2023 | $5–10 |
| 2024 | $7–12 |
| 2025 | $8–13 |
| 2026 | $10–12 |
Insight: After an initial IPO surge, FIGS faced a decline due to broader market corrections, but recent stabilization indicates a potential growth phase.
Financial Statements Analysis
Let’s break down the financial health of FIGS using the latest data.
Income Statement Highlights
Revenue growth and profitability are the key indicators of financial performance.
| Fiscal Year | Revenue ($M) | Net Income ($M) | EPS ($) |
|---|---|---|---|
| 2022 | 250 | 30 | 0.30 |
| 2023 | 275 | 35 | 0.35 |
| 2024 | 300 | 40 | 0.40 |
| 2025 | 310 | 38 | 0.38 |
Takeaway: FIGS shows steady revenue growth, although net income in 2025 slightly dipped, reflecting higher costs and investment in marketing and expansion.
Balance Sheet Highlights
Checking assets, liabilities, and equity gives insights into financial stability.
| Year | Total Assets ($M) | Total Liabilities ($M) | Equity ($M) |
|---|---|---|---|
| 2022 | 400 | 150 | 250 |
| 2023 | 420 | 160 | 260 |
| 2024 | 450 | 170 | 280 |
| 2025 | 470 | 175 | 295 |
Observation: FIGS has strong equity growth and manageable liabilities — a positive sign for financial stability.
Cash Flow Statement Highlights
Cash flow indicates operational efficiency and liquidity.
| Year | Operating CF ($M) | Investing CF ($M) | Financing CF ($M) |
|---|---|---|---|
| 2022 | 50 | -20 | -15 |
| 2023 | 55 | -25 | -20 |
| 2024 | 60 | -30 | -25 |
| 2025 | 62 | -28 | -22 |
Key Insight: FIGS maintains positive operating cash flow, showing it can generate cash to cover operations while investing in growth.
Valuation Metrics (2026)
Valuation helps understand if a stock is overvalued, undervalued, or fairly priced.
| Metric | Value |
|---|---|
| Price-to-Earnings (P/E) | 110x |
| Forward P/E | 104x |
| Price-to-Book (P/B) | 6.0 |
| Price-to-Sales (P/S) | 3.2 |
| PEG Ratio | 1.5 |
Interpretation: FIGS’ P/E is high, reflecting strong growth expectations but also higher risk. PEG ratio indicates moderate growth potential relative to earnings.
Market Trends & Competitor Analysis
Healthcare Apparel Industry Trends
- Direct-to-Consumer Growth: Online sales and subscriptions are rising.
- Sustainability: Eco-friendly scrubs and fabrics are becoming popular.
- Comfort & Style: Professionals prefer functional yet stylish apparel.
Key Competitors
| Competitor | Market Strength | Weakness |
|---|---|---|
| Medelita | High-quality fabrics | High price |
| Barco Uniforms | Established brand | Less innovative |
| Uniform Advantage | Affordable pricing | Limited product variety |
| Cherokee Uniforms | Wide distribution | Lower quality |
Insight: FIGS competes well with unique products but faces intense market competition.
Investment Considerations
Pros
- Strong brand recognition
- Consistent revenue growth
- Innovative products and direct-to-consumer model
Cons
- High valuation multiples
- Market volatility
- Competitive industry landscape
Personal Insights & Recommendations
From my research, FIGS is promising for long-term investors who believe in growth in healthcare apparel. However, short-term traders should be cautious due to volatility and high valuation. My advice: watch quarterly earnings, competitor moves, and industry trends before investing.
Conclusion
To sum up, FIGS stock offers brand strength, niche dominance, and growth potential, but comes with risks like high valuation and market volatility. For investors ready to take a long-term view, FIGS can be an interesting option in the healthcare apparel sector.
Stay updated, analyze the market regularly, and make informed decisions before investing.
